Abattis Bioceuticals Corp. announced the following key additions to Executive and Management team, Anthony Jackson as Chief Financial Officer ("CFO"), Christina Boddy as Corporate Secretary, John Kaye as head of Corporate Development and Clayton Chessa as head of Operations. All positions will report directly to Robert Abenante, President and CEO of Abattis.

Anthony Jackson is a Chartered Accountant (CPA, CA) with an impressive track record of providing financial consultant and CFO services to various public and private companies. Prior to becoming a founder and principle at BridgeMark Financial Corp, Mr. Jackson worked at Ernst &Young and as a senior analyst with an investment banking firm. Mr. Jackson has led strategic ventures within the cannabis industry and is a welcome addition to Abattis.

Christina Boddy is an experienced corporate governance professional with over ten years' experience acting as Corporate Secretary for public companies listed on the Toronto Stock Exchange, TSX Venture Exchange, and the Canadian Securities Exchange. Ms. Boddy will play the lead role in ensuring regulatory and compliance requirements at Abattis are met. John Kaye has over 10 years of experience in active business operations as well as significant experience in investment banking and mergers and acquisitions ("M&A").

Mr. Kaye joins Abattis after his time as an M&A associate at Sequoia Mergers &Acquisitions, a sell-side M&A firm in Vancouver. He will lead corporate development efforts for the Company. Clayton Chessa has been working in the Canadian cannabis industry for nearly 10 years, developing a keen sense for the nuances and specifics of this booming industry.

This firsthand experience has given Mr. Chessa the opportunity to transition into consultancy services where he has guided industry operators in areas such as financial and managerial systems and consultation on growing, testing, extracting, distribution and general operations within the sector. Mr. Chessa brings a unique skill set to Abattis and an educated view on the current landscape surrounding the legal cannabis industry in Canada.